-
Survivor Profile
Living in the Here and NowA metastatic melanoma survivor is hopeful but realistic as new treatments become available.
by Jenny Song
-
The Power of 1
Studies focused on individuals rather than large numbers of people can help some patients while advancing knowledge.
by Stephen Ornes
-
The High-Deductible Gamble
High-deductible health insurance plans can leave cancer patients scrambling to pay the bills for tests and treatments.
by Charlotte Huff
-
In the Moment- Spring 2016
Colleen Bokor, Dana Stewart, Brittany Avin.
-
Survivor Profile
Changing CourseDuring her treatment for breast cancer, biomedical engineer Jessica Winter challenged her laboratory to bring its discoveries to patients more quickly.
by Chris Palmer
-
Yesterday & Today
A Storied LifeLiterary realist John Updike used the scaffold of his own life, including his lung cancer diagnosis, to explore the shared experiences of our time.
by Sue Rochman
-
Honor Your Body
Coming to terms with feelings and emotions about weight gain and weight loss is often part of a cancer patient's experience.
by Sue Rochman
-
In the Moment- Winter 2015/2016
Jared Levinthall, Carol Dellinger, Anne Ha.
-
Colorectal Cancer: A Troubling Trend
More people are being diagnosed with colorectal cancer before 50, the recommended age to start screening.
by Charlotte Huff
Cancer Talk
Understanding How High and Low Testosterone Levels Can Treat Prostate Cancer
Using high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.
by Sandra Gordon
Financial Screenings for People with CancerCancer patients say they want to be asked about their financial needs on a regular basis.
by Pamela Appea
Let Me Tell You a Story About the Power of Medical ResearchTen-year-old Michael Methner told his story about being diagnosed with optic nerve glioma at the AACR’s Rally for Medical Research.
by Cancer Research Catalyst
Aggressive Approach to Very Advanced Cancer Does Not Extend SurvivalStudy shows no benefit from treatment for cancers at very advanced stages of progression. Researchers urge end-of-life planning for these patients.
by Kyle Bagenstose